524768 EMMESSA

Emmessar Biotech & Nutrition Share Price

 

 

Start SIP in EMMESSA

Start SIP

Performance

  • Low
  • ₹26
  • High
  • ₹29
  • 52 Week Low
  • ₹24
  • 52 Week High
  • ₹43
  • Open Price₹29
  • Previous Close₹28
  • Volume2,008
  • 50 DMA₹28.35
  • 100 DMA₹29.42
  • 200 DMA₹31.14

Investment Returns

  • Over 1 Month -8.36%
  • Over 3 Month -11.58%
  • Over 6 Month + 0.4%
  • Over 1 Year -22.11%

Smart Investing Starts Here Start SIP with Emmessar Biotech & Nutrition for Steady Growth!

Invest Now

Emmessar Biotech & Nutrition Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 41.1
  • PEG Ratio
  • -0.7
  • Market Cap Cr
  • 14
  • P/B Ratio
  • 1.7
  • Average True Range
  • 2.36
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.57
  • RSI
  • 42.41
  • MFI
  • 42.8

Emmessar Biotech & Nutrition Financials

Emmessar Biotech & Nutrition Technicals

EMA & SMA

Current Price
₹27.41
-0.39 (-1.4%)
pointer
  • Bearish Moving Average 9
  • Bullish Moving Average 7
  • 20 Day
  • ₹27.36
  • 50 Day
  • ₹28.35
  • 100 Day
  • ₹29.42
  • 200 Day
  • ₹31.14

Resistance and Support

27.14 Pivot Speed
  • R3 30.58
  • R2 29.69
  • R1 28.03
  • S1 25.48
  • S2 24.59
  • S3 22.93

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Emmessar Biot.& Nut. has an operating revenue of Rs. 0.37 Cr. on a trailing 12-month basis. An annual revenue growth of 3% is not great, Pre-tax margin of 157% is great, ROE of 4% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 32 which is a POOR score indicating inconsistency in earnings, a RS Rating of 44 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 100 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Emmessar Biotech & Nutrition Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-11 Quarterly Results
2025-11-12 Quarterly Results
2025-08-07 Quarterly Results
2025-04-24 Audited Results
2025-02-06 Quarterly Results

Emmessar Biotech & Nutrition F&O

Emmessar Biotech & Nutrition Shareholding Pattern

59.53%
0.05%
0.14%
38.09%
2.19%

About Emmessar Biotech & Nutrition

  • NSE Symbol
  • EMMESSA
  • BSE Symbol
  • 524768
  • Managing Director
  • Mr. Srinivasa Raghavan Mathurakavi Ayyangar
  • ISIN
  • INE634B01016

Similar Stocks to Emmessar Biotech & Nutrition

Emmessar Biotech & Nutrition FAQs

Emmessar Biotech & Nutrition share price is ₹27 As on 13 February, 2026 | 00:27

The Market Cap of Emmessar Biotech & Nutrition is ₹13.7 Cr As on 13 February, 2026 | 00:27

The P/E ratio of Emmessar Biotech & Nutrition is 41.1 As on 13 February, 2026 | 00:27

The PB ratio of Emmessar Biotech & Nutrition is 1.7 As on 13 February, 2026 | 00:27

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23